The latest thought leadership from our expert teams

Active filters (1)
eBook

Creating robust bioprocessing scale-down models

18th May 2021

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • Bioinnovation
Whitepaper

Building the business of biodesign

27th Mar 2018

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Strategic advice
Opinion

Our sustainable materials database is enabling innovation in the drive to net zero

10th Jun 2021

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Sustainability
Opinion

Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing

8th Jun 2021

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

  • Bioinnovation
Opinion

Rethinking Materials – it’s time to deliver some wins in packaging sustainability

27th May 2021

With the world becoming increasingly impatient for a great sustainability reset, last week’s inaugural Rethinking Materials Virtual Summit did a pretty decent job at starting to shape the agenda for innovation in plastics and packaging over the next five or so years.

  • Bioinnovation
Webinar

Beyond AlphaFold: achieving new levels of protein performance through direct function prediction

17th May 2021

Watch our webinar to discover how deep learning is allowing us to design optimized protein sequences to perform beyond those found in nature.

  • AI & Analytics
  • Bioinnovation
  • Strategic advice
Opinion

The challenge of scale down models

10th May 2021

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

  • Bioinnovation
Opinion

CellPreserve: our innovation could help prolong the lives of cancer patients

7th Apr 2021

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

  • Bioinnovation
  • Digital health
Opinion

Tri-Con 2021 reflects the rapid pace of development in diagnostics

8th Mar 2021

The past year has seen an unprecedented acceleration of innovation in the diagnostics space. Reflecting on the virtual themes and debates at Molecular Med Tri-Con 2021, Head of Life Sciences Symon Cotton says that the speed of tests and vaccines coming to market is not having an adverse effect on quality. Medical developments can be safely delivered to quicker timescales...

  • Bioinnovation
  • Digital health
  • Human factors
Opinion

What’s next for targeted medicine? We report back from SLAS 2021

4th Feb 2021

Symon Cotton, Head of Life Sciences at Cambridge Consultants, attended this year’s Society for Laboratory Automation and Screening conference, SLAS2021. Even in virtual form, the speakers dazzled with fresh and exciting ideas for the future of patient treatments.

  • Bioinnovation
  • Digital health
Opinion

Our core technology is at the heart of the world’s first FDA-approved fully at-home COVID-19 test

22nd Jan 2021

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

  • Bioinnovation
  • Digital health
  • Fluids & thermodynamics
  • Sensing
Opinion

UK Human Tissue Authority licence enhances our next-generation therapy development

17th Dec 2020

We are delighted to report a significant step forward as we grow our bioinnovation capability as we have received our licence from the UK Human Tissue Authority to store human tissue for research purposes. This opens the way to future development in cell therapies and regenerative medicine. 

  • Bioinnovation